BRUCE R. BISTRIAN

Bruce R. Bistrian is a distinguished professor at Harvard University, where he leads pioneering research in clinical nutrition and metabolism. He holds a prominent position within the university's medical and nutritional sciences community. Dr. Bistrian's educational background provided the foundation for his lifelong dedication to understanding the role of nutrition in health and disease. His research program is centered on clinical nutrition and gastroenterology, with a particular emphasis on nutrition and health in aging, as well as diet and metabolism studies. A core and highly impactful theme of his recent work investigates the role of intravenous omega-3 fatty acid triglycerides, particularly from fish oil, in mitigating cytokine release syndrome associated with advanced cancer therapies like CAR T-cell treatment and immune-modulating chemotherapy. This research bridges nutritional science, pharmacology, and oncology, aiming to modulate inflammatory responses within the tumor microenvironment. His extensive publication record, comprising 587 papers and an h-index of 73, also encompasses foundational studies on parenteral and enteral nutrition, iron homeostasis in obesity and bariatric surgery, and the broader physiological impacts of nutritional support. Dr. Bistrian's contributions have significantly advanced the scientific understanding of how specialized nutritional formulations can be used therapeutically to improve patient outcomes in critical care and complex metabolic conditions. Their research directions are illustrated by key works including "Circulating ghrelin concentrations are lowered by intravenous glucose or hyperinsulinemic euglycemic conditions in rodents", and "The New Dietary Fats in Health and Disease".